Edaravone
FDA Approved: * May 6, 2024Pharm Company: * HIKMA PHARMACEUTICALS USA INC
Category: Neurological Disorders
Edaravone, sold as under the brand names Radicava and Radicut among others, is an intravenous medication used to help with recovery following a stroke and to treat amyotrophic lateral sclerosis (ALS).[1][2] The label carries a warning about the potential for hypersensitivity reactions to edaravone, and adverse effects include bruising, gait disturbances, headache, skin inflammation, eczema, problems breathing, excess sugar in urine, and fungal skin infections.&... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Edaravone 30 mg/100ml Intravenous Injection, Solution
NDC: 39822-4500
Labeler:
Xgen Pharmaceuticals Djb, Inc.
Edaravone 60 mg/100ml Intravenous Injection, Solution
NDC: 39822-4510
Labeler:
Xgen Pharmaceuticals Djb, Inc.
Edaravone 30 mg/100ml Intravenous Injection, Solution
NDC: 66794-259
Labeler:
Piramal Critical Care Inc.